Gotham Asset Management, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 185 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
Gotham Asset Management, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$264,257
-20.4%
8,791
-14.4%
0.01%
-40.0%
Q1 2022$332,000
+0.9%
10,264
-9.0%
0.01%
-9.1%
Q4 2021$329,000
+21.4%
11,274
+10.8%
0.01%0.0%
Q3 2021$271,000
+5.4%
10,177
-5.9%
0.01%
+37.5%
Q2 2020$257,000
-68.2%
10,812
-76.0%
0.01%
-63.6%
Q1 2020$809,000
-58.6%
44,979
-45.4%
0.02%
-38.9%
Q4 2019$1,956,000
-31.3%
82,447
-20.4%
0.04%
-28.0%
Q3 2019$2,846,000
-13.2%
103,550
+4.5%
0.05%
-3.8%
Q2 2019$3,278,000
+11.0%
99,073
+17.6%
0.05%
+20.9%
Q1 2019$2,953,000
+125.9%
84,265
+114.1%
0.04%
+115.0%
Q4 2018$1,307,000
+221.9%
39,352
+387.9%
0.02%
+233.3%
Q3 2018$406,000
+6.3%
8,065
+26.5%
0.01%0.0%
Q2 2018$382,000
-74.6%
6,376
-80.5%
0.01%
-71.4%
Q1 2018$1,501,000
-73.0%
32,781
-76.5%
0.02%
-74.1%
Q4 2017$5,563,000
-17.5%
139,597
-17.2%
0.08%
-18.2%
Q3 2017$6,741,000
+541.4%
168,536
+591.3%
0.10%
+560.0%
Q2 2017$1,051,000
-67.1%
24,381
-76.1%
0.02%
-63.4%
Q1 2017$3,193,000
+1157.1%
102,001
+719.0%
0.04%
+1266.7%
Q2 2016$254,000
-5.2%
12,455
-29.0%
0.00%0.0%
Q1 2016$268,000
-41.0%
17,552
-48.1%
0.00%
-40.0%
Q4 2015$454,000
-17.3%
33,808
-13.6%
0.01%0.0%
Q3 2015$549,000
-63.4%
39,142
-55.7%
0.01%
-61.5%
Q2 2015$1,499,000
+197.4%
88,267
+111.7%
0.01%
+225.0%
Q1 2015$504,00041,6860.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders